Skip to main content
. 2019 Jun 24;10(17):3926–3932. doi: 10.7150/jca.31345

Figure 1.

Figure 1

Validation of somatic mutations in nasopharyngeal carcinoma (NPC). A combination of polymerase chain reaction (PCR) and Sanger-sequencing techniques was used to validate previously identified somatic mutations in tumor and blood (negative control) samples collected from patients with NPC. The depicted GPC6 G-C mutation was found to occur more frequently in the analyzed tumor than in blood samples.